Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M45.0Revenue $M1.1Net Margin (%)-1,247.6Altman Z-Score-14.7
Enterprise Value $M39.6EPS $-0.3Operating Margin %-1,339.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-1,247.3Higher ROA y-yY
Price/Book18.910-y EBITDA Growth Rate %--Quick Ratio1.9Cash flow > EarningsY
Price/Sales29.35-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-141.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-264.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M61.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NBY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NBY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NBY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pioneer Pharma (Singapore) Pte10% Owner 2015-03-03Buy2,590,000$0.623.33 view
SIECZKAREK MARK MDirector 2015-03-03Buy166,666$0.623.33 view
Najafi RaminChairman 2015-03-03Buy166,666$0.623.33 view
Najafi RaminChairman 2014-12-12Buy50,000$0.6513.85 view
PAULSON THOMAS JCFO 2014-12-12Buy10,000$0.688.82 view
Stroman David W.SVP, Ophthalmic Product Devt. 2014-12-12Buy10,000$0.6612.12 view
Najafi RaminChairman 2014-12-11Buy20,000$0.623.33 view
PAULSON THOMAS JCFO 2014-12-09Buy10,000$0.6710.45 view
Najafi RaminChairman 2014-12-05Buy25,000$0.6513.85 view
Wicks Tony D.S.Director 2014-12-02Sell20,000$0.75.71 view

Press Releases about NBY :

    Quarterly/Annual Reports about NBY:

    News about NBY:

    Articles On GuruFocus.com
    Own it Feb 29 2012 
    NovaBay Pharmaceuticals Inc. (NBY) Chairman Ramin Najafi buys 1,000 Shares Aug 28 2009 
    NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results Aug 14 2009 

    More From Other Websites
    Panning for Golden Stocks Outside the Gold Industry May 28 2015
    SeeThruEquity Initiates Coverage on NovaBay Pharmaceuticals with a Price Target of $1.87 May 27 2015
    Doctors Embrace Avenova™ for Common Eye Conditions May 27 2015
    NOVABAY PHARMACEUTICALS, INC. Financials May 22 2015
    NovaBay Announces $6.86 Million “At Market” Private Placement May 22 2015
    NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... May 22 2015
    NovaBay Announces $6.86 Million “At Market” Private Placement May 22 2015
    10-Q for NovaBay Pharmaceuticals, Inc. May 17 2015
    NovaBay Pharmaceuticals Reports 2015 First Quarter Financial Results and Provides Business Update May 14 2015
    NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 14 2015
    NovaBay Pharmaceuticals Reports 2015 First Quarter Financial Results and Provides Business Update May 14 2015
    NovaBay Pharmaceuticals to Feature Key Opinion Leaders in Ophthalmology and Optometry at Analyst and... May 12 2015
    NovaBay Pharmaceuticals to Feature Key Opinion Leaders in Ophthalmology and Optometry at Analyst and... May 11 2015
    NovaBay Pharmaceuticals to Feature Key Opinion Leaders in Ophthalmology and Optometry at Analyst and... May 11 2015
    NovaBay Pharmaceuticals’ Avenova Brings Significant Improvement to Patients with Blepharitis, New... May 06 2015
    New Laboratory Study Shows that NovaBay Pharmaceuticals’ Avenova Completely Inactivates the... May 06 2015
    NovaBay Pharmaceuticals’ Avenova Brings Significant Improvement to Patients With Blepharitis, New... May 06 2015
    New Laboratory Study Shows that NovaBay Pharmaceuticals’ Avenova Completely Inactivates the... May 06 2015
    NovaBay Pharmaceuticals Receives Noncompliance Notice from NYSE MKT May 06 2015
    NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... May 01 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK